Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.
about
Pleiotropic effects of statinsRole of lipotoxicity in endothelial dysfunctionCombination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease.Gene variations of ROCKs and risk of ischaemic stroke: the Women's Genome Health Study.Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.Rho kinase as a therapeutic target in cardiovascular disease.Rho-GTPase and Atherosclerosis: Pleiotropic Effects of StatinsMeasurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudilRho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials.Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.Pleiotropic Effects of Statins on the Cardiovascular System.Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemiaEffects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
P2860
Q26783220-8F6AC63B-7629-49AA-98BE-67304F0D9E88Q27000731-C055BE41-2CF9-4AC6-915C-4733FD3D0B03Q31076799-60CB4244-FABA-4F92-BCEA-170AB2FFE057Q33764027-6D274C00-E576-42BB-975A-5BA362F21E58Q33776230-9A1DACAB-7C3A-4BA2-BBD4-F12A7E4A7A9FQ34562019-678CC603-26F0-40E7-8FF1-A124800BB39EQ35352722-5FB35502-3A02-48EE-B41E-C0D904AB90F6Q36168823-084B35AE-214F-4C6B-B004-D8C4F635B74AQ37252134-E11AFF92-8110-4EE9-8181-2A70284D6F6AQ37450106-B6866F54-E8ED-4E18-B42D-57B9199857ABQ37709733-261C8D36-72AB-4011-B87A-24CAF220F6BCQ38104228-EA1F3BC0-C251-4466-ADE2-A1DEBFEE422DQ38471162-F8E1F52D-69EE-426E-8AB9-CE20CCBC3E58Q39069187-8133396D-0C05-4BBC-9AD7-1A42B5FCA6DCQ41893725-F26BC27D-E378-4F4E-8305-3F530657BB11Q54533235-7117CC73-B053-4B6E-B667-83EA122DC69D
P2860
Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of effects of rosuv ...... revious atherosclerotic event.
@en
Comparison of effects of rosuvastatin
@nl
type
label
Comparison of effects of rosuv ...... revious atherosclerotic event.
@en
Comparison of effects of rosuvastatin
@nl
prefLabel
Comparison of effects of rosuv ...... revious atherosclerotic event.
@en
Comparison of effects of rosuvastatin
@nl
P2093
P2860
P1476
Comparison of effects of rosuv ...... revious atherosclerotic event.
@en
P2093
Andrew Selwyn
Anju Nohria
James K Liao
Jason Donnelly
Mark A Creager
Peter Ganz
Ping-Yen Liu
Ron Rawlings
P2860
P304
P356
10.1016/J.AMJCARD.2008.10.008
P407
P577
2008-12-25T00:00:00Z